Role of central muscarinic cholinergic receptors in the formalin-induced pain in rats

Abstract

Objectives: In the present study, central effects of physostigmine and atropine have investigated in the formalin-induced pain in rats.

Materials and methods: In conscious rats implanted with an intracerebroventricular (i.c.v.) cannula, the effects of i.c.v. injection of physostigmine and atropine were investigated on the formalin test in the rat. Formalin test was induced by subcutaneous (s.c.) injection of formalin (50 mul, 1%) in ventral surface of left hind paw, and durations of licking and biting of the injected paw were measured in 5-min blocks for 1 h.

Results: FORMALIN PRODUCED A BIPHASIC RESPONSE (FIRST PHASE: 0-5 and second phase: 15-40 min) in durations of licking and biting of the injected paw. Physostigmine at doses of 2.5, 5 and 10 ug significantly (P < 0.05) attenuated both first and second phases of pain response. Atropine (5 and 10 ug), used alone, produced no significant effect on pain, but pretreatment with atropine (10 ug) significantly (P < 0.05) blocked antinociception induced by physostigmine (5 ug).

Conclusion: These results indicate that i.c.v. physostigmine can affect both neurogenic and inflammatory phases of formalin-induced pain through a mechanism in which the muscarinic cholinergic receptors are involved.

Keywords: Atropine; brain; formalin-induced pain; physostigmine; rats.

Figure 1

Effect of i.c.v. injection of physostigmine on the formal-ininduced pain in rats. Each column represents mean ± SEM (n = 6). *P < 0.05 vs. control (one-way ANOVA followed by Duncan's test). i.p.l.: intraplantar, i.c.v.: intracerebroventricular

Figure 2

Effect of i.c.v. injection of atropine on physostigmine-induced changes in formalin-induced pain in rats. Each column represents mean ± SEM (n = 6). *P < 0.05 vs. other groups (one-way ANOVA followed by Duncan's test). i.p.l.: intraplantar, i.c.v.: intracerebroventricular